Last updated: March 26, 2025
Sponsor: University Hospital, Grenoble
Overall Status: Active - Recruiting
Phase
N/A
Condition
Allergies & Asthma
Allergy
Hives (Urticaria)
Treatment
N/AClinical Study ID
NCT06806618
3824.0394
Ages > 12 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
For the patient population:
Patients with a confirmed diagnosis of HAE with a deficit in the C1 inhibitor.
Aged ≥12 years
Having consulted for HAE in the last 3 months and with a medical file.
For the caregiver population:
- A person identified by the patient as part of their support group and who providessupport with the management of the patients HAE (including family members, friends,spouse, etc.)
Exclusion
Exclusion Criteria:
For the patient population:
Opposes to participating in the study.
Patients is under guardianship or deprived of their liberty.
Study Design
Total Participants: 300
Study Start date:
March 01, 2025
Estimated Completion Date:
April 30, 2025
Study Description
Connect with a study center
CHU Grenoble Alpes
Grenoble,
FranceActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.